Immunotherapy in Head and Neck Cancer-Ready for Prime Time or More Research Needed?

Int J Radiat Oncol Biol Phys. 2021 Mar 1;109(3):647-650. doi: 10.1016/j.ijrobp.2020.11.022.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review
  • Comment

MeSH terms

  • Head and Neck Neoplasms* / therapy
  • Humans
  • Immunologic Factors
  • Immunotherapy

Substances

  • Immunologic Factors